Prostaglandins and cystoid macular edema

Survey of Ophthalmology

Volumn 47, Issue 4 SUPPL. 1, 2002, Pages

  Miyake, Kensaku ^a   Ibaraki, Nobuhiro ^b  

^a Miyake Eye Hospital   (Japan)

^b NIPPON MEDICAL SCHOOL CHIBA HOKUSOH HOSPITAL   (Japan)

Author keywords

Blood aqueous barrier; Blood retinal barrier; Cystoid macular edema (CME); Latanoprost; Nonsteroidal anti inflammatory drugs (NSAIDs); Preservative maculopathy; Prostaglandins (PGs); Soluble chemical mediators; Timolol

Indexed keywords

ARACHIDONIC ACID; BETAMETHASONE; DICLOFENAC; ENDOTHELIN 1; FLUOROMETHOLONE; INDOMETACIN; LATANOPROST; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN DERIVATIVE; PROSTAGLANDIN SYNTHASE INHIBITOR; TIMOLOL; VASCULOTROPIN;

APHAKIA; AQUEOUS HUMOR; BLOOD RETINA BARRIER; CLINICAL TRIAL; GLAUCOMA; HUMAN; INFLAMMATION; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; META ANALYSIS; NONHUMAN; PATHOGENESIS; PHACOEMULSIFICATION; PRIORITY JOURNAL; RETINA MACULA CYSTOID EDEMA; REVIEW;

EID: 0036669682     PISSN: 00396257     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6257(02)00294-1     Document Type: Article

References (114)

1. Ketorolac tromethamine. Med Lett Drugs Ther. 32:1990;79-81.
2. Abdel-Latif A.A., Zhang Y., Yousufzai S.Y. Endothelin-1 stimulates the release of arachidonic acid and prostaglandins in rabbit iris sphincter smooth muscle. activation of phospholipase A2 Curr Eye Res. 10:1991;259-265.
3. Abelson M.B., Smith L.M., Ormerod L.D. Prospective, randomized trial of oral piroxicam in the prophylaxis of postoperative cystoid macular edema. J Ocul Pharmacol. 5:1989;147-153.
4. Ahluwalia B.K., Kalra S.C., Parmar I.P., Khurana A.K. A comparative study of the effect of antiprostaglandins and steroids on aphakic cystoid macular oedema. Indian J Ophthalmol. 36:1988;176-178.
5. Ahmed A., Dearn S., Shams M.et al. Localization, quantification, and activation of platelet-activating factor receptor in human endometrium during the menstrual cycle. PAF stimulates NO, VEGF, and FAKpp125 FASEB J. 12:1998;831-843.
6. Alpar J.J., McGuigan L., Alpar A.J.et al. Effect of diclofenac sodium ophthalmic 0.1% on inflammation following cataract extraction. A fluorophotometry study (abstract) Ophthalmology. 96(Suppl):1989;109.
7. Ambache N., Kavanagh L., Whiting J. Effect of mechanical stimulation on rabbits eye. Release of active substance in anterior chamber perfusates J Physiol (Lond). 176:1965;378-408.
8. Artaria LG: [Prevention of cystoid macular edema with O-beta-hydroxyethyl-rutoside (Venoruton) in a double-blind study]. Klin Monatsbl Augenheilkd 180:568-70, 1982.
9. Ayyala R.S., Cruz D.A., Margo C.E.et al. Cystoid macular edema associated with latanoprost in aphakic and pseudophakic eyes. Am J Ophthalmol. 126:1998;602-604.
10. Bazan N.G., Allan G. Signal transduction and gene expression in the eye. a contemporary view of the pro-inflammatory, anti-inflammatory and modulatory roles of prostaglandins and other bioactive lipids Surv Ophthalmol. 41(Suppl 2):1997;S23-S34.
11. Bhattacherjee P., Eakins K.E. Inhibition of the prostaglandin synthetase systems in ocular tissues by indomethacin. Br J Pharmacol. 50:1974;227-230.
12. Bhattacherjee P., Kulkarni P.S., Eakins K.E. Metabolism of arachidonic acid in rabbit ocular tissues. Invest Ophthalmol Vis Sci. 18:1979;172-178.
13. Binkhorst C.D. Corneal and retinal complications after cataract extraction. The mechanical aspect of endophthalmodonesis. Ophthalmology. 87:1980;609-617.
14. Bito L.Z. Prostaglandins. a new approach to glaucoma management with a new, intriguing side effect Surv Ophthalmol. 41(Suppl 2):1997;S1-S14.
15. Bito L.Z., Salvador E.V. Intraocular fluid dynamics. 3. The site and mechanism of prostaglandin transfer across the blood intraocular fluid barriers. Exp Eye Res. 14:1972;233-241.
16. Burnett J., Tessler H., Isenberg S., Tso M.O. Double-masked trial of fenoprofen sodium. treatment of chronic aphakic cystoid macular edema Ophthalmic Surg. 14:1983;150-152.
17. Callanan D., Fellman R.L., Savage J.A. Latanoprost-associated cystoid macular edema. Am J Ophthalmol. 126:1998;134-135.
18. Christ E.J., van Dorp D.A. Comparative aspects of prostaglandin biosynthesis in animal tissues. Biochim Biophys Acta. 270:1972;534-545.
19. Collins W.P., Hennan J.F. The measurement of local hormone and metabolites. Recommended method. Mol Asp Med. 1:1976;114-117.
20. de Lima W.T., Kwasniewski F.H., Sirois P., Jancar S. Studies on the mechanism of PAF-induced vasopermeability in rat lungs. Prostaglandins Leukot Essent Fatty Acids. 52:1995;245-249.
21. Duke-Elder WS: Diseases of the Uvela Tract, in Systems of Ophthalmology, London, UK, Henry Kimpton, 1971, vol. 9, pp213-15
22. Eakins K.E. Prostaglandins and prostaglandin synthetase inhibitors. Action in ocular disease Robinson H.J., Vane J.R. Prostaglandins synthetase inhibitors. 1974;Raven Press, New York.
23. Eakins K.E., Whitelocke R.A., Bennett A., Martenet A.C. Prostaglandin-like activity in ocular inflammation. Br Med J. 3:1972;452-453.
24. Fine B.S., Brucker A.J. Macular edema and cystoid macular edema. Am J Ophthalmol. 92:1981;466-481.
25. Flach A.J. Cyclo-oxygenase inhibitors in ophthalmology. Surv Ophthalmol. 36:1992;259-284.
26. Flach A.J., Dolan B.J., Irvine A.R. Effectiveness of ketorolac tromethamine 0.5% ophthalmic solution for chronic aphakic and pseudophakic cystoid macular edema. Am J Ophthalmol. 103:1987;479-486.
27. Flach A.J., Jampol L.M., Weinberg D.et al. Improvement in visual acuity in chronic aphakic and pseudophakic cystoid macular edema after treatment with topical 0.5% ketorolac tromethamine. Am J Ophthalmol. 112:1991;514-519.
28. Flach A.J., Kraff M.C., Sanders D.R., Tanenbaum L. The quantitative effect of 0.5% ketorolac tromethamine solution and 0.1% dexamethasone sodium phosphate solution on postsurgical blood- aqueous barrier. Arch Ophthalmol. 106:1988;480-483.
29. Flach A.J., Lavelle C.J., Olander K.W.et al. The effect of ketorolac tromethamine solution 0.5% in reducing postoperative inflammation after cataract extraction and intraocular lens implantation. Ophthalmology. 95:1988;1279-1284.
30. Flach A.J., Stegman R.C., Graham J., Kruger L.P. Prophylaxis of aphakic cystoid macular edema without corticosteroids. A paired-comparison, placebo-controlled double-masked study. Ophthalmology. 97:1990;1253-1258.
31. Fu J.Y., Masferrer J.L., Seibert K.et al. The induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytes. J Biol Chem. 265:1990;16737-16740.
32. Fujii E., Irie K., Uchida Y.et al. Role of eicosanoids but not nitric oxide in the platelet-activating factor-induced increase in vascular permeability in mouse skin. Eur J Pharmacol. 273:1995;267-272.
33. Gass J.D., Norton E.W. Cystoid macular edema and papilledema following cataract extraction. A fluorescein fundoscopic and angiographic study. Arch Ophthalmol. 76:1966;646-661.
34. Hanna C., Sharp J.D. Ocular absorption of indomethacin by the rabbit. Arch Ophthalmol. 88:1972;196-198.
35. Hayasaka S., Masuda K. Ocular irritation and lysosomal enzymes in aqueous humor. Part II. Lysosomal enzymes after paracentesis, intracameral injection of PGE2, neutral formaldehyde instillation, or fifth nerve stimulation. Folia Ophthalmol Jpn. 31:1980;1269-1272.
36. Heier J.S., Steinert R.F., Frederick A.R. Jr. Cystoid macular edema associated with latanoprost use. Arch Ophthalmol. 116:1998;680-682.
37. Henry M.M., Henry L.M., Henry L.M. A possible cause of chronic cystic maculopathy. Ann Ophthalmol. 9:1977;455-457.
38. Higginbotham E.J. Will latanoprost be the wonder drug of the 90s for the treatment of glaucoma? Arch Ophthalmol. 114:1996;998-999.
39. Hollwich F., Jacobi K., Kuchle H.J. Zur Prophylaxe des zystoiden Makulaodems mit Indomethacin-Augentropfen. Klin Monatsbl Augenheilkd. 183:1983;477-478.
40. Ibaraki N., Goto Y., Kobayashi S., Miyake K. Effects of latanoprost and timolol maleate on the expression of cytokine in human lens epithelial SRA01/04 cells. Invest Ophtalmol Vis Sci. 42(Suppl):2001;289. [abstract].
41. Irvine S.R. A newly defined vitreous syndrome following cataracts surgery. Interpreted according to recent concepts of the structure of the vitreous. Am J Ophthalmol. 36:1953;599-619.
42. Kass M.A., Holmberg N.J. Prostaglandin and thromboxane synthesis by microsomes of rabbit ocular tissues. Invest Ophthalmol Vis Sci. 18:1979;166-171.
43. Keates E.U., Gerber D.S. Prophylactic topical indomethacin in patients undergoing planned extracapsular cataract extraction. Res Clin Forums. 7:1985;13-19.
44. Keates R.H., McGowan K.A. Clinical trial of flurbiprofen to maintain pupillary dilation during cataract surgery. Ann Ophthalmol. 16:1984;919-921.
45. Keates R.H., McGowan K.A. The effect of topical indomethacin ophthalmic solution in maintaining mydriasis during cataract surgery. Ann Ophthalmol. 16:1984;1116-1121.
46. Kent D., Vinores S.A., Campochiaro P.A. Macular oedema. the role of soluble mediators Br J Ophthalmol. 84:2000;542-545.
47. Keulen-de Vos H.C., van Rij G., Renardel de Lavalette J.C., Jansen J.T. Effect of indomethacin in preventing surgically induced miosis. Br J Ophthalmol. 67:1983;94-96.
48. Kolker A.E., Becker B. Epinephrine maculopathy. Arch Ophthalmol. 79:1968;552-562.
49. Kraff M.C., Sanders D.R., Jampol L.M.et al. Prophylaxis of pseudophakic cystoid macular edema with topical indomethacin. Ophthalmology. 89:1982;885-890.
50. Kraff M.C., Sanders D.R., McGuigan L., Raanan M.G. Inhibition of blood-aqueous humor barrier breakdown with diclofenac. A fluorophotometric study. Arch Ophthalmol. 108:1990;380-383.
51. Krishnan M.M., Lath N.K., Govind A. Aphakic macular edema. some observations on prevention and pathogenesis Ann Ophthalmol. 17:1985;253-257.
52. Kujubu D.A., Fletcher B.S., Varnum B.C.et al. TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J Biol Chem. 266:1991;12866-12872.
53. Malecaze F., Chollet P., Cavrois E.et al. Role of interleukin 6 in the inflammatory response after cataract surgery. An experimental and clinical study. Arch Ophthalmol. 109:1991;1681-1683.
54. Masuda K., Izawa Y., Mishima S. Prostaglandins and uveitis. a preliminary report Jpn J Ophthalmol. 17:1973;166-170.
55. Mehelas T.J., Kollarits C.R., Martin W.G. Cystoid macular edema presumably induced by dipivefrin hydrochloride (Propine). Am J Ophthalmol. 94:1982;682.
56. Michels R.G., Maumenee A.E. Cystoid macular edema associated with topically applied epinephrine in aphakic eyes. Am J Ophthalmol. 80:1975;379-388.
57. Mishima S, Masuda K: Clinical implications of prostaglandins and synthesis inhibitors, in Leopold IH, Burns RP (eds): Symposium on Ocular Therapy, New York, Wiley & Sons, 1977, Vol. 10, pp 1-19.
58. Miyake K. Cystoid macular edema as part of diffuse intraocular symptoms. Folia Ophthalmol Jpn. 46:1995;219-231.
59. Miyake K. Nonsteroidal anti-inflammatory agents in cataract intraocular lens surgery. Curr Opin Ophthalmol. 6:1995;62-65.
60. Miyake K. Indomethacin in the treatment of postoperative cystoid macular edema. Surv Ophthalmol. 28(Suppl):1984;554-568.
61. Miyake K. Prevention of cystoid macular edema after lens extraction by topical indomethacin. (II) A control study in bilateral extraction. Jpn J Ophthalmol. 22:1978;80-94.
62. Miyake K. Prevention of cystoid macular edema after lens extraction by topical indomethacin (I). A preliminary report. Albrecht Von Graefes Arch Klin Exp Ophthalmol. 203:1977;81-88.
63. Miyake K., Kayazawa F., Manabe R., Miyake Y. Indomethacin and the epinephrine-induced breakdown of the blood-ocular barrier in rabbits. Invest Ophthalmol Vis Sci. 28:1987;482-486.
64. Miyake K., Maekubo K., Miyake Y., Nishi O. Pupillary fibrin membrane. A frequent early complication after posterior chamber lens implantation in Japan. Ophthalmology. 96:1989;1228-1233.
65. Miyake K., Masuda K., Shirato S.et al. Comparison of diclofenac and fluorometholone in preventing cystoid macular edema after small incision cataract surgery. a multicentered prospective trial Jpn J Ophthalmol. 44:2000;58-67.
66. Miyake K., Mibu H., Horiguchi M., Shirasawa E. Inflammatory mediators in postoperative aphakic and pseudophakic baboon eyes. Arch Ophthalmol. 108:1990;1764-1767.
67. Miyake K., Miyake Y., Kuratomi R. Long-term effects of topically applied epinephrine on the blood-ocular barrier in humans. Arch Ophthalmol. 105:1987;1360-1363.
68. Miyake K., Ota I., Ibaraki N.et al. Enhanced disruption of the blood-aqueous barrier and the incidence of angiographic cystoid macular edema by topical timolol and its preservative in early postoperative pseudophakia. Arch Ophthalmol. 119:2001;387-394.
69. Miyake K., Ota I., Maekubo K.et al. Latanoprost accelerates disruption of the blood-aqueous barrier and the incidence of angiographic cystoid macular edema in early postoperative pseudophakias. Arch Ophthalmol. 117:1999;34-40.
70. Miyake K., Sakamura S., Miura H. Long-term follow-up study on prevention of aphakic cystoid macular oedema by topical indomethacin. Br J Ophthalmol. 64:1980;324-328.
71. Miyake K., Shirasawa E., Hikita M. Active transport system of prostaglandins. clinical implications and considerations J Cataract Refract Surg. 18:1992;100-105.
72. Miyake K., Shirasawa E., Hikita M.et al. Synthesis of prostaglandin E in rabbit eyes with topically applied epinephrine. Invest Ophthalmol Vis Sci. 29:1988;332-334.
73. Miyake K., Sugiyama S., Norimatsu I. Aqueous prostaglandins in persistent cystoid macular edema secondary to vitreous incarceration. effects of pars plana vitrectomy Jpn J Ophthalmol. 24:1980;335-345.
74. Miyake K., Sugiyama S., Norimatsu I. Prevention of cystoid macular edema after lens extraction by topical indomethacin. (III) Radioimmunoassay measurement of prostaglandins in the aqueous during and after lens extraction procedures. Albrecht Von Graefes Arch Klin Exp Ophthalmol. 209:1978;83-88.
75. Mochizuki M. Transport of indomethacin in the anterior uvea of the alvino rabbit. Jpn J Ophthalmol. 24:1980;363-373.
76. Mochizuki M., Sawa M., Masuda K. Topical indomethacin in the intracapsular extraction of senile cataract. Jpn J Opthalmol. 21:1977;215-226.
77. Mondino B.J., Nagata S., Glovsky M.M. Activation of the alternative complement pathway by intraocular lenses. Invest Ophthalmol Vis Sci. 26:1985;905-908.
78. Murata T., Nakagawa K., Khalil A.et al. The relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retinas. Lab Invest. 74:1996;819-825.
79. Nishi O., Nishi K., Imanishi M. Synthesis of interleukin-1 and prostaglandin E2 by lens epithelial cells of human cataracts. Br J Ophthalmol. 76:1992;338-341.
80. Nussler A.K., Billiar T.R. Inflammation, immunoregulation, and inducible nitric oxide synthase. J Leukoc Biol. 54:1993;171-178.
81. O'Banion M.K., Sadowski H.B., Winn V., Young D.A. A serum- and glucocorticoid-regulated 4-kilobase mRNA encodes a cyclooxygenase-related protein. J Biol Chem. 266:1991;23261-23267.
82. Ozaki H., Hayashi H., Vinores S.A.et al. Intravitreal sustained release of VEGF causes retinal neovascularization in rabbits and breakdown of the blood-retinal barrier in rabbits and primates. Exp Eye Res. 64:1997;505-517.
83. Quentin CD, Behrens-Baumann W, Gaus W: [Prevention of cystoid macular edema with diclofenac eyedrops in intracapsular cataract extraction using the Choyce Mark IX anterior chamber lens]. Fortschr Ophthalmol 86:546-9, 1989.
84. Ramirez M.M., Quardt S.M., Kim D.et al. Platelet activating factor modulates microvascular permeability through nitric oxide synthesis. Microvasc Res. 50:1995;223-234.
85. Raz A., Wyche A., Needleman P. Temporal and pharmacological division of fibroblast cyclooxygenase expression into transcriptional and translational phases. Proc Natl Acad Sci USA. 86:1989;1657-1661.
86. Reese A.B., Jones I.S., Cooper W.C. Macular changes secondary to vitreous traction. Trans Am Ophthalmol Soc. 64:1966;123-134.
87. Roper D.L., Nisbet R.M. Effect of hyaluronidase on the incidence of cystoid macular edema. Ann Ophthalmol. 10:1978;1673-1678.
88. Rosenthal AL, deFaller JM, Reaves TA: Clinical evaluation of suprofen in cataract surgery. Proceedings of the XXVth International Congress of Ophthalmology: Rome, May 4-10, 1986. Berkeley: Kugler & Ghedini, 2481-4, 1987.
89. Rossetti L., Chaudhuri J., Dickersin K. Medical prophylaxis and treatment of cystoid macular edema after cataract surgery. The results of a meta-analysis. Ophthalmology. 105:1998;397-405.
90. Sanders D.R., Kraff M. Steroidal and nonsteroidal anti-inflammatory agents. Effect on postsurgical inflammation and blood-aqueous humor barrier breakdown. Arch Ophthalmol. 102:1984;1453-1456.
91. Sawa M., Masuda K. Topical indomethacin in soft cataract aspiration. Jpn J Ophthalmol. 20:1976;514-519.
92. Schumer R.A., Camras C.B., Mandahl A.K. Latanoprost and cystoid macular edema. is there a causal relation? Curr Opin Ophthalmol. 11:2000;94-100.
93. Sears M.L., Neufeld A.H., Jampol L.M. Prostaglandins. Invest Ophthalmol. 12:1973;161-164.
94. Shoji N, Oshika T, Masuda K: [Anterior chamber inflammation after the injection of endothelin-1 into the vitreous and the effect of an anti-prostaglandin agent]. Nippon Ganka Gakkai Zasshi 101:209-14, 1997.
95. Sholiton D.B., Reinhart W.J., Frank K.E. Indomethacin as a means of preventing cystoid macular edema following intracapsular cataract extraction. J Am Intraocul Implant Soc. 5:1979;137-140.
96. Sirois M.G., Edelman E.R. VEGF effect on vascular permeability is mediated by synthesis of platelet-activating factor. Am J Physiol. 272:1997;H2746-H2756.
97. Solomon L.D. Efficacy of topical flurbiprofen and indomethacin in preventing pseudophakic cystoid macular edema. Flurbiprofen-CME Study Group I. J Cataract Refract Surg. 21:1995;73-81.
98. Stark W.J., Fagadau W.R., Stewart R.H.et al. Reduction of pupillary constriction during cataract surgery using suprofen. Arch Ophthalmol. 104:1986;364-366.
99. Stark W.J. Jr., Maumenee A.E., Fagadau W.et al. Cystoid macular edema in pseudophakia. Surv Ophthalmol. 28(Suppl):1984;442-451.
100. Stjernschantz J., Resul B. Phenyl-substituted prostaglandin analogs to glaucoma treatment. Drugs Future. 17:1992;691-701.
101. Tolentino F.I., Schepens C.L. Edema of posterior pole after cataract extraction. a biomicroscopic study Arch Ophthalmol. 74:1965;781-786.
102. Urner-Bloch U: [Prevention of cystoid macular edema following cataract extraction using local indomethacin application]. Klin Monatsbl Augenheilkd 183:479-84, 1983.
103. van Dorp D.A., Jouvenaz G.H., Struijk C.B. The biosynthesis of prostaglandin in pig eye iris. Biochim Biophys Acta. 137:1967;396-399.
104. Vinores S.A., Chan C.C., Vinores M.A.et al. Increased vascular endothelial growth factor (VEGF) and transforming growth factor beta (TGFbeta) in experimental autoimmune uveoretinitis. upregulation of VEGF without neovascularization J Neuroimmunol. 89:1998;43-50.
105. Vinores S.A., Sen H., Campochiaro P.A. An adenosine agonist and prostaglandin E1 cause breakdown of the blood- retinal barrier by opening tight junctions between vascular endothelial cells. Invest Ophthalmol Vis Sci. 33:1992;1870-1878.
106. Vinores S.A., Youssri A.I., Luna J.D.et al. Upregulation of vascular endothelial growth factor in ischemic and non-ischemic human and experimental retinal disease. Histol Histopathol. 12:1997;99-109.
107. Waitzman M.B. Possible new concepts relating prostaglandins to various ocular functions. Surv Ophthalmol. 14:1970;301-326.
108. Waitzman M.B., King C.D. Prostaglandin influences on intraocular pressure and pupil size. Am J Physiol. 212:1967;329-334.
109. Wolter J.R. The histopathology of cystoid macular edema. Albrecht Von Graefes Arch Klin Exp Ophthalmol. 216:1981;85-101.
110. Worst JG: [Biotoxic effects of aqueous humour-a unifying pathogenetic theory, based on certain hypothetic biotoxic factors in aqueus (authors transl)]. Klin Monatsbl Augenheilkd 167:376-84, 1975.
111. Yannuzzi L.A., Klein R.M., Wallyn R.H.et al. Ineffectiveness of indomethacin in the treatment of chronic cystoid macular edema. Am J Ophthalmol. 84:1977;517-519.
112. Yannuzzi L.A., Landau A.N., Turtz A.I. Incidence of aphakic cystoid macular edema with the use of topical indomethacin. Ophthalmology. 88:1981;947-954.
113. Yokoyama T: [Interleukin-1 beta in the aqueous humor in aphakic and pseudophakic eyes of rabbits]. Nippon Ganka Gakkai Zasshi 96:67-73, 1992.
114. Yousufzai S.Y., Abdel-Latif A.A. Effects of platelet-activating factor on the release of arachidonic acid and prostaglandins by rabbit iris smooth muscle. Inhibition by calcium channel antagonists. Biochem J. 228:1985;697-706.